Dror Bashan - Apr 11, 2022 Form 4 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
President and CEO, Director
Signature
/s/ Dror Bashan
Stock symbol
PLX
Transactions as of
Apr 11, 2022
Transactions value $
$102,000
Form type
4
Date filed
4/13/2022, 04:05 PM
Previous filing
Feb 28, 2022
Next filing
Sep 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLX Common Stock Purchase $102K +68K $1.50 68K Apr 11, 2022 Direct F1
holding PLX Common Stock 1.09M Apr 11, 2022 By Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person holds the shares in an account with his spouse as joint tenants.
F2 Represents restricted shares of common stock of Protalix BioTherapeutics, Inc., awarded to the employee under its Amended and Restated 2006 Stock Incentive Plan, as amended June 7, 2020. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Plan must be registered in the name of a trustee.